volume 130 issue 6 pages 831-847

Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis

Sabrina Robichaud 1, 2
Adil Rasheed 1, 2
Antonietta Pietrangelo 1, 2
Anne Doyoung Kim 1, 2
Dominique M. Boucher 1, 2
Christina Emerton 1
Viyashini Vijithakumar 1, 2
Lara Gharibeh 1, 2
Garrett Fairman 1, 2
Esther Mak 1
My-Anh Nguyen 1, 2
Michele Geoffrion 1
Robert Wirka 3
Katey J Rayner 1, 2
Mireille Ouimet 1, 2
Publication typeJournal Article
Publication date2022-02-09
scimago Q1
wos Q1
SJR4.897
CiteScore24.2
Impact factor16.2
ISSN00097330, 15244571
Cardiology and Cardiovascular Medicine
Physiology
Abstract
Rationale:

Atherosclerosis is characterized by an accumulation of foam cells within the arterial wall, resulting from excess cholesterol uptake and buildup of cytosolic lipid droplets (LDs). Autophagy promotes LD clearance by freeing stored cholesterol for efflux, a process that has been shown to be atheroprotective. While the role of autophagy in LD catabolism has been studied in macrophage-derived foam cells, this has remained unexplored in vascular smooth muscle cell (VSMC)-derived foam cells that constitute a large fraction of foam cells within atherosclerotic lesions.

Objective:

We performed a comparative analysis of autophagy flux in lipid-rich aortic intimal populations to determine whether VSMC-derived foam cells metabolize LDs similarly to their macrophage counterparts.

Methods and Results:

Atherosclerosis was induced in GFP-LC3 (microtubule-associated proteins 1A/1B light chain 3) transgenic mice by PCSK9 (proprotein convertase subtilisin/kexin type 9)-adeno-associated viral injection and Western diet feeding. Using flow cytometry of aortic digests, we observed a significant increase in dysfunctional autophagy of VSMC-derived foam cells during atherogenesis relative to macrophage-derived foam cells. Using cell culture models of lipid-loaded VSMCs and macrophages, we show that autophagy-mediated cholesterol efflux from VSMC foam cells was poor relative to macrophage foam cells, and largely occurs when HDL (high-density lipoprotein) was used as a cholesterol acceptor, as opposed to apoA-1 (apolipoproteinA-1). This was associated with the predominant expression of ABCG1 in VSMC foam cells. Using metformin, an autophagy activator, cholesterol efflux to HDL was significantly increased in VSMC, but not in macrophage, foam cells.

Conclusions:

These data demonstrate that VSMC and macrophage foam cells perform cholesterol efflux by distinct mechanisms, and that autophagy flux is highly impaired in VSMC foam cells, but can be induced by pharmacological means. Further investigation is warranted into targeting autophagy specifically in VSMC foam cells, the predominant foam cell subtype of advanced atherosclerotic plaques, to promote reverse cholesterol transport and resolution of the atherosclerotic plaque.

Found 
Found 

Top-30

Journals

1
2
3
International Journal of Molecular Sciences
3 publications, 4.05%
Biomedicine and Pharmacotherapy
3 publications, 4.05%
Biomolecules
2 publications, 2.7%
Cell Death and Disease
2 publications, 2.7%
Current Atherosclerosis Reports
2 publications, 2.7%
Current Problems in Cardiology
2 publications, 2.7%
Journal of Advanced Research
2 publications, 2.7%
ACS Nano
2 publications, 2.7%
Journal of Nanobiotechnology
2 publications, 2.7%
Metabolism: Clinical and Experimental
2 publications, 2.7%
Journal of Translational Medicine
1 publication, 1.35%
Current Opinion in Lipidology
1 publication, 1.35%
Circulation Research
1 publication, 1.35%
Frontiers in Physiology
1 publication, 1.35%
Frontiers in Genetics
1 publication, 1.35%
Advanced Functional Materials
1 publication, 1.35%
Clinical and Experimental Medicine
1 publication, 1.35%
WIREs Mechanisms of Disease
1 publication, 1.35%
Nature Reviews Cardiology
1 publication, 1.35%
The Analyst
1 publication, 1.35%
Microvascular Research
1 publication, 1.35%
FASEB Journal
1 publication, 1.35%
Phytotherapy Research
1 publication, 1.35%
Cardiology
1 publication, 1.35%
Science China Life Sciences
1 publication, 1.35%
Expert Opinion on Therapeutic Targets
1 publication, 1.35%
Frontiers in Cardiovascular Medicine
1 publication, 1.35%
European Journal of Medical Research
1 publication, 1.35%
Phytomedicine
1 publication, 1.35%
1
2
3

Publishers

2
4
6
8
10
12
14
16
18
Elsevier
17 publications, 22.97%
Springer Nature
15 publications, 20.27%
MDPI
8 publications, 10.81%
Frontiers Media S.A.
5 publications, 6.76%
Cold Spring Harbor Laboratory
5 publications, 6.76%
American Chemical Society (ACS)
5 publications, 6.76%
Ovid Technologies (Wolters Kluwer Health)
4 publications, 5.41%
Wiley
4 publications, 5.41%
Royal Society of Chemistry (RSC)
2 publications, 2.7%
Taylor & Francis
2 publications, 2.7%
Oxford University Press
2 publications, 2.7%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 1.35%
S. Karger AG
1 publication, 1.35%
Research Square Platform LLC
1 publication, 1.35%
Impact Journals
1 publication, 1.35%
AME Publishing Company
1 publication, 1.35%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
74
Share
Cite this
GOST |
Cite this
GOST Copy
Robichaud S. et al. Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis // Circulation Research. 2022. Vol. 130. No. 6. pp. 831-847.
GOST all authors (up to 50) Copy
Robichaud S., Rasheed A., Pietrangelo A., Doyoung Kim A., Boucher D. M., Emerton C., Vijithakumar V., Gharibeh L., Fairman G., Mak E., Nguyen M., Geoffrion M., Wirka R., Rayner K. J., Ouimet M. Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis // Circulation Research. 2022. Vol. 130. No. 6. pp. 831-847.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1161/CIRCRESAHA.121.320047
UR - https://doi.org/10.1161/CIRCRESAHA.121.320047
TI - Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis
T2 - Circulation Research
AU - Robichaud, Sabrina
AU - Rasheed, Adil
AU - Pietrangelo, Antonietta
AU - Doyoung Kim, Anne
AU - Boucher, Dominique M.
AU - Emerton, Christina
AU - Vijithakumar, Viyashini
AU - Gharibeh, Lara
AU - Fairman, Garrett
AU - Mak, Esther
AU - Nguyen, My-Anh
AU - Geoffrion, Michele
AU - Wirka, Robert
AU - Rayner, Katey J
AU - Ouimet, Mireille
PY - 2022
DA - 2022/02/09
PB - Ovid Technologies (Wolters Kluwer Health)
SP - 831-847
IS - 6
VL - 130
PMID - 35137605
SN - 0009-7330
SN - 1524-4571
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Robichaud,
author = {Sabrina Robichaud and Adil Rasheed and Antonietta Pietrangelo and Anne Doyoung Kim and Dominique M. Boucher and Christina Emerton and Viyashini Vijithakumar and Lara Gharibeh and Garrett Fairman and Esther Mak and My-Anh Nguyen and Michele Geoffrion and Robert Wirka and Katey J Rayner and Mireille Ouimet},
title = {Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis},
journal = {Circulation Research},
year = {2022},
volume = {130},
publisher = {Ovid Technologies (Wolters Kluwer Health)},
month = {feb},
url = {https://doi.org/10.1161/CIRCRESAHA.121.320047},
number = {6},
pages = {831--847},
doi = {10.1161/CIRCRESAHA.121.320047}
}
MLA
Cite this
MLA Copy
Robichaud, Sabrina, et al. “Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis.” Circulation Research, vol. 130, no. 6, Feb. 2022, pp. 831-847. https://doi.org/10.1161/CIRCRESAHA.121.320047.